The case was seen as a test of a more aggressive policy by the agency.
Related Posts
Pennsylvania House Votes to Scrutinize Private-Equity Healthcare Takeovers
The Pennsylvania House of Representatives has passed landmark legislation (House Bill 1460) imposing unprecedented oversight on private-equity healthcare transactions, marking a watershed moment in...
BioNTech Consolidates mRNA Leadership with Strategic $1.25 Billion CureVac Acquisition
In a landmark consolidation of Germany's biotechnology sector, BioNTech SE (NASDAQ: BNTX) has announced its acquisition of CureVac NV (NASDAQ: CVAC) through an all-stock transaction valued at $1.25...
Advent International’s $175M Bet on Felix Pharma Signals Strategic Shift in Animal Health Generics
Private equity giant Advent International has positioned itself at the forefront of the emerging animal health generics market through a $175 million strategic investment in Ireland-based Felix...
Craneware Rejects Bain Capital’s £939M Takeover Bid: Strategic Implications for Healthcare SaaS Valuations
Edinburgh-based healthcare SaaS provider Craneware has rebuffed a £26.50-per-share acquisition proposal from Bain Capital, asserting the $1.3 billion valuation fundamentally misprices its market...